Biotech Growth Trust plc (The) (BIOG) Ordinary 25p
6.00p
(0.62%)
- Add to watchlist
- Create an alert
- This stock can be held in a
6.00p
(0.62%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
6.00p
(0.62%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
972.00p
976.84p
1,278.00p
1,064.02
975.00p
962.21p
725.00p
-9.21%
9.00p (0.93%) Previous:
9.00p
27,264
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
| 1 week 1W | 0.61% | 1 year 1Y | 16.52% |
|---|---|---|---|
| 1 month 1M | 11.05% | 2 years 2Y | 20.21% |
| 3 months 3M | 18.9% | 3 years 3Y | 24.05% |
| 6 months 6M | 3.61% | 5 years 5Y | 23.81% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
| Benchmark: | NASDAQ Biotechnology TR GBP |
|---|---|
| Annual management charge: | n/a |
| Performance fee: | No |
| Ongoing charge: | 1.10% |
| Dividend yield: | n/a |
| Dividend frequency: | None |
| Total assets: | £482m |
| Gross gearing: | 111% |
| Market capitalisation:Market cap.: | £393m |
| Shares in issue: | 40.71 million |
| Legal structure | Closed Ended Investment Company |
| Domicile: | United Kingdom |
| ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
Objective
NET ASSET VALUE (NAV)
| Estimated NAV: | 1,064.02 |
|---|---|
| Latest actual NAV: | 921.36 |
| Latest actual NAV date: | 22 February 2022 |
| Premium/Discount: | -9.21% |
| 12m average Premium/Discount: | -3.96% |
| NAV frequency: | Daily |
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
| Security | Weight |
|---|---|
| Biomarin Pharmaceutical Inc | 5.54% |
| Seagen Inc Ordinary Shares | 4.89% |
| Horizon Therapeutics plc Ordinary Shares | 4.78% |
| Keros Therapeutics Inc | 4.73% |
| Syndax Pharmaceuticals Inc | 4.21% |
| GH Research PLC | 4.11% |
| Yisheng B - Pfd | 4.09% |
| Xenon Pharmaceuticals Inc | 3.87% |
| Gilead Sciences Inc | 3.70% |
| Vaxcyte Inc Ordinary Shares | 3.52% |
| Sector | Weight |
|---|---|
| Healthcare | 100.32% |
| Country | Weight |
|---|---|
| United States | 79.56% |
| Canada | 7.29% |
| China | 5.46% |
| Ireland | 4.11% |
| United Kingdom | 2.48% |
| France | 0.53% |
| Germany | 0.34% |
| Switzerland | 0.29% |
| Singapore | 0.23% |
| Denmark | 0.10% |
Key Dates
| Launch date: | 23 June 1997 |
|---|---|
| Financial year end: | March |
| Next AGM: | July 2023 |
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.